Dr. Anthenelli in the Press:
NEW: Pac-TARC researchers contribute to the development of pharmacological treatment for tobacco use disorder
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES)
Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
NEW: Pac-TARC researchers contribute to the development of pharmacological treatment for tobacco use disorder
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES)
- Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
- Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial
Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
Relevant News and Media:
Community Involvement
NAMI Walk 2017 at Liberty Station, San Diego
|
Recovery Happens 2017 at Liberty Station, San Diego
|
NAMI Walk 2018 at Liberty Station, San Diego
UCSD Team at the NAMI Walk 2019 at Liberty Station, San Diego
